IP Library › Patent Application 11325602
Patent Application
App. No. 11/325,602

Thiol-based NAALADase inhibitors

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/325,602
Abstract

This invention relates to new compounds, pharmaceutical compositions and diagnostic kits comprising such compounds, and methods of using such compounds for inhibiting NAALADase enzyme activity, detecting diseases where NAALADase levels are altered, effecting neuronal activity, effecting TGF-β activity, inhibiting angiogenesis and treating glutamate abnormalities, diabetic neuropathy, pain, compulsive disorders, prostate diseases, cancers and glaucoma.

Claims (4)

1 . A compound of formula I

or a pharmaceutically acceptable equivalent of said compound, wherein:

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are independently hydrogen or C 1 -C 3 alkyl;

A 1 , A 2 , A 3 and A 4 are independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halo, nitro, phenyl, phenoxy, benzyloxy or —COOH, or any adjacent two of A 2 , A 3 and A 4 form with the benzene ring a fused 5- or 6-membered carbocyclic or heterocyclic aromatic ring, said heterocyclic aromatic ring containing 1 or 2 oxygen, nitrogen and/or sulfur heteroatom(s).